This act reforms Medicare Advantage prior authorization by mandating an audit to standardize requirements for high-cost, evidence-supported items and services, with exemptions for providers in certain two-sided risk models.
Sheldon Whitehouse
Senator
RI
The Prior Authorization Relief Act aims to streamline and standardize prior authorization requirements within Medicare Advantage plans. It mandates an audit to identify high-cost items, services, and drugs with excessive authorization steps. Based on the findings, the bill requires the standardization of these prior authorization processes across all Medicare Advantage plans, with certain exemptions for providers in two-sided financial risk models.
Medicare Advantage Reform Targets Red Tape: New Standardization for High-Cost Care by 2028
The Prior Authorization Relief Act aims to cut through the bureaucratic maze that often delays medical care for seniors. By January 1, 2027, the government must audit Medicare Advantage plans to find high-cost treatments and drugs that are currently buried under an 'excessive' amount of paperwork. Once these bottlenecks are identified, the Secretary of Health and Human Services has until May 1, 2028, to roll out a single, standardized set of rules for these services across all plans. This means if you are managing a chronic condition that requires expensive specialty drugs, your path to approval could become a lot more predictable regardless of which insurance company you use.
Cutting Through the Paperwork Jungle
Under the current system, every insurance provider has its own unique set of hoops for doctors to jump through before they can treat a patient. This bill targets the top 10 percent of most expensive reimbursements where clinical evidence for the treatment is already clear. For a patient waiting on a high-cost procedure, like a complex surgery or a specialized infusion, this could mean fewer days spent in 'pending' status while an office manager faxes the same forms for the third time. By standardizing these requirements (Section 2), the bill tries to ensure that the rules of the game don't change just because you switched from one Medicare Advantage provider to another.
The 'Risk' Reward for Doctors
The bill also introduces a 'fast track' for certain medical groups. If your doctor belongs to an Accountable Care Organization (ACO) or another model where the medical practice shares the financial risk of your care, they could be exempt from these standardized rules entirely. The logic is that if a doctor is already financially on the hook for keeping you healthy and keeping costs down, they don't need a middleman checking their homework. For you, this could mean that a specialist can greenlight a treatment during your appointment without having to wait for a call back from your insurance company.
The Fine Print and Potential Loopholes
While the goal is efficiency, there are a few areas where the implementation could get messy. The bill uses the phrase 'excessive number of steps' to describe the paperwork it wants to eliminate, but it doesn't actually define what 'excessive' means. This leaves a lot of room for interpretation during the 2027 audit. Additionally, Medicare Advantage plans are given a 'veto' power of sorts: they can ask the government to ignore the exemption for those risk-sharing doctors. If the government approves these requests, the streamlined process for integrated care could be blocked, leaving patients and doctors stuck with the old, complex approval systems they were trying to escape.